-
Only 1 in 4 Adolescent Treatment Facilities Offer Buprenorphine for Opioid Use Disorder
Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study. Only 1 in 8 offer buprenorphine for ongoing treatment. These findings highlight a significant gap in...
-
Increased Use of Telehealth for OUD Services During COVID-19 Pandemic Associated With Reduced Risk of Overdose
The expansion of telehealth services for opioid use disorder (OUD) during the COVID-19 pandemic was associated with individuals staying in treatment longer and reducing their risk of medically treated overdose, according to a new study. Published today in JAMA Psychiatry, this study was a...
-
Buprenorphine Initiation in the ER Found Safe and Effective for Individuals With Opioid Use Disorder Who Use Fentanyl
Results from a multi-site clinical trial supported by the National Institutes of Health showed that less than 1% of people with opioid use disorder whose drug use includes fentanyl experienced withdrawal when starting buprenorphine in the ER. The findings, which appeared today in JAMA Network Open,...
-
NIH Research Matters – Telehealth Improves Treatment for Opioid Use Disorder
Telehealth improves treatment for opioid use disorder for people during the COVID-19 pandemic, increasing the likelihood of staying on their medications and less likely to overdose. The findings support continuing the expanded telehealth access that began during the pandemic. Medications...
-
Behavioral Health News Spotlight on Excellence: An Interview with Mary Brewster, Associate Commissioner for Harm Reduction at the New York State Office of Addiction Services and Supports (OASAS)
Overview David Minot, Executive Director of Mental Health News Education, the non-profit organization that publishes Behavioral Health News, interviewed Mary Brewster, Associate Commissioner for Harm Reduction at the New York State Office of Addiction Services and Supports (OASAS). The mission of...
-
The NYSPA Report: Overdose Prevention Centers Keep Our People Alive
People with opioid use disorder (OUD) have a high prevalence of a serious mental illness (SMI). Nearly 27% of people with an OUD had a co-occurring SMI (Jones and McCance-Katz 2019), which complicates care when access to dual diagnosis treatment is limited. Overdose deaths have steadily increased...
-
NY State Department of Health Warns the Public in Central New York About Alarming Increase In Opioid Overdoses
Providers and Public Encouraged to Take Advantage of New Standing Order, Allowing New Yorkers to Get Naloxone Without a Prescription On August 26, 2022, The New York State Department of Health has been made aware of a rapid increase in opioid-related overdoses in the Central New York region....
-
Percentage of Overdose Deaths Involving Methadone Declined Between January 2019 and August 2021
National data indicate COVID-era treatment expansion was not associated with harms, add evidence to support take-home treatment for opioid use disorder The percentage of methadone-involved overdose deaths relative to all drug overdose deaths declined from January 2019 to August 2021, according...
-
The Department of Health and Human Services Announces Funding for Substance Use Treatment and Prevention Programs
The Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), is announcing two grant programs totaling $25.6 million that will expand access to medication-assisted treatment for opioid use disorder and prevent the misuse of...
-
NIH Research Matters – Treatment for Opioid Use Disorder in Jail Reduces Risk of Return
Almost two-thirds of people currently incarcerated in the U.S. have a substance use disorder. Many struggle with opioid addiction. Opioids include prescription pain relievers, heroin, and powerful synthetic versions such as fentanyl that are driving record numbers of overdose deaths. Medications...
